Sophia Randolph - Jul 1, 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF MEDICAL OFFICER, Director
Signature
/s/ Peter Garcia, by power of attorney
Stock symbol
ALXO
Transactions as of
Jul 1, 2024
Transactions value $
-$19,045
Form type
4
Date filed
7/3/2024, 05:02 PM
Previous filing
May 15, 2024
Next filing
Aug 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Sale -$19K -3.27K -0.99% $5.82 327K Jul 1, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.